https://www.selleckchem.com/pr....oducts/GSK429286A.ht
ptions in areas of unmet need is given with the context of new molecular imaging possibilities and cutting edge advances in nuclear medicine. With recent advances in technology, patients with acute respiratory distress syndrome (ARDS) and severe acute exacerbations of chronic obstructive pulmonary disease (ae-COPD) could benefit from extracorporeal CO removal (ECCO R). However, current evidence in these indications is limited. A European ECCO R Expert Round Table Meeting was convened to further explore the potential for this treatmen
Like
Comment
Share
